IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 366 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,159 | -99.9% | 30,706 | -1.9% | 0.00% | 0.0% |
| Q3 2022 | $1,384,000 | +71.3% | 31,306 | +74.1% | 0.00% | +100.0% |
| Q1 2021 | $808,000 | -42.8% | 17,977 | -28.1% | 0.00% | -66.7% |
| Q4 2020 | $1,413,000 | +34.4% | 24,986 | +12.8% | 0.00% | 0.0% |
| Q3 2020 | $1,051,000 | -12.4% | 22,151 | +8.9% | 0.00% | 0.0% |
| Q2 2020 | $1,200,000 | +39.0% | 20,346 | +11.6% | 0.00% | 0.0% |
| Q1 2020 | $863,000 | -38.8% | 18,235 | -22.0% | 0.00% | +50.0% |
| Q4 2019 | $1,411,000 | +10.0% | 23,369 | +9.1% | 0.00% | -33.3% |
| Q3 2019 | $1,283,000 | -51.4% | 21,420 | -47.8% | 0.00% | +200.0% |
| Q2 2019 | $2,638,000 | +65850.0% | 41,046 | +87231.9% | 0.00% | – |
| Q1 2019 | $4,000 | – | 47 | +840.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 5 | -99.2% | 0.00% | – |
| Q2 2016 | $15,000 | -44.4% | 663 | +0.6% | 0.00% | – |
| Q1 2016 | $27,000 | – | 659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |